TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  Benzinga

Pfizer Accuses Novo Nordisk Of Antitrust Violations In Metsera Takeover Battle

Benzinga Logo Benzinga • •By Vandana Singh
Pfizer Accuses Novo Nordisk Of Antitrust Violations In Metsera Takeover Battle

Pfizer filed a lawsuit against Metsera and Novo Nordisk in Delaware Court, alleging antitrust violations and breach of contract after Novo Nordisk made an unsolicited $9 billion acquisition proposal that could disrupt Pfizer's planned $4.9 billion acquisition of Metsera.

Insights
PFE   negative

Actively pursuing legal action to block a competing acquisition proposal, indicating defensive strategic positioning